R

Rallybio Corp
NASDAQ:RLYB

Watchlist Manager
Rallybio Corp
NASDAQ:RLYB
Watchlist
Price: 0.7415 USD -3.7% Market Closed
Market Cap: 31.3m USD

Wall Street
Price Targets

RLYB Price Targets Summary
Rallybio Corp

Wall Street analysts forecast RLYB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RLYB is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

Lowest
Price Target
1.01 USD
36% Upside
Average
Price Target
1.02 USD
38% Upside
Highest
Price Target
1.05 USD
42% Upside
Rallybio Corp Competitors:
Price Targets
KALV
Kalvista Pharmaceuticals Inc
87% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
43% Upside
XOMA
XOMA Corp
172% Upside
PTCT
PTC Therapeutics Inc
11% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
8% Upside
DAWN
Day One Biopharmaceuticals Inc
170% Upside

Revenue
Forecast

Revenue Estimate
Rallybio Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Rallybio Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Rallybio Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RLYB's stock price target?
Price Target
1.02 USD

According to Wall Street analysts, the average 1-year price target for RLYB is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

Back to Top